WeedLife News Network
DeFloria’s advances cannabis-based autism drug through early trial
If successful in later trials, it could become one of the first FDA-approved botanical drugs derived from hemp for autism spectrum disorder. DeFloria announced Thursday that its experimental cannabis-based drug for autism spectrum disorder showed positive early results, with patients tolerating the
Copyright
© 420 Intel
When you subscribe to the blog, we will send you an e-mail when there are new updates on the site so you wouldn't miss them.